alchemia...what else...., page-3

Arcterix, I reread your post and in your opinion you say Merck will try and buy ACL, which could hold merit as they are doing the phase II with Erbitux and would know how good this thing is. So what would be a fair price for Alchemia???? Especially considering HAI alone is worth $M450 - $B1.5, then in years to come HA for SCLC is a $B10 market. I would be gutted if we get great results to get less than $3 a share knowing this is the first drug of many trials to follow. Is there any history where a buyout has occurred at 5 times the current share price.? After being in this thing for 8years I'd be pretty pissed to only double my money if we crack this thing. Ok people, I'm keen for your opinions what price would be fair for ACL after a successful Phase III